Nektar Therapeutics - NKTR - stock price prediction, stock price target, analyst ratings from 10 analysts

Nektar Therapeutics has a share price target of US$ 153, revenue growth forecast of -25.4%, and profit growth estimate of -51.5% for FY26, based on top 10 analyst calls.